Oxcarbazepine in the management of behavioral agitation in community-dwelling patients with Alzheimer's disease: An open-label study

被引：0
|
作者：
Shua-Haim, J [1 ]
机构：
[1] Alzheimers Res Corp, Dept Med, Lakehurst, NJ USA
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2003年 / 13卷
关键词：
D O I：
10.1016/S0924-977X(03)92318-2
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S434 / S434
页数：1
相关论文
共 50 条
  • [21] Management of psychosis, agitation, and other behavioral problems in Alzheimer's disease
    Lake, JT
    Grossberg, GT
    PSYCHIATRIC ANNALS, 1996, 26 (05) : 274 - 279
  • [22] Safety and efficacy of dronabinol in the treatment of agitation in patients with Alzheimer's disease: A pilot study in community dwelling patients refractory to traditional medicine
    Shua-Haim, JR
    Pass, MD
    Patel, S
    Patel, S
    Lee, P
    NEUROBIOLOGY OF AGING, 2004, 25 : S331 - S331
  • [23] An Open-Label, Pilot Study of Daratumumab SC in Mild to Moderate Alzheimer's Disease
    Gordon, Marc L.
    Christen, Erica
    Keehlisen, Lynda
    Gong, Michelle
    Lam, Fung
    Giliberto, Luca
    Gomar, Jesus J.
    Koppel, Jeremy
    JOURNAL OF ALZHEIMERS DISEASE REPORTS, 2024, 8 (01) : 1111 - 1114
  • [24] An open-label study of Escitalopram (Lexapro®) for the treatment of 'Depression of Alzheimer's disease' (dAD)
    Rao, V
    Spiro, JR
    Rosenberg, PB
    Lee, HB
    Rosenblatt, A
    Lyketsos, CG
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2006, 21 (03) : 273 - 274
  • [25] Spared and Impaired Abilities in Community-Dwelling Patients Entering the Severe Stage of Alzheimer's Disease
    Gillioz, Anne-Sophie
    Villars, Helene
    Voisin, Thierry
    Cortes, Frederic
    Gillette-Guyonnet, Sophie
    Andrieu, Sandrine
    Gardette, Virginie
    Nourhashemi, Fati
    Ousset, Pierre-Jean
    Jouanny, Pierre
    Vellas, Bruno
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2009, 28 (05) : 427 - 432
  • [26] Depressive symptoms in Alzheimer's disease -: An examination among community-dwelling Cuban American patients
    Harwood, DG
    Barker, WW
    Ownby, RL
    Bravo, M
    Aguero, H
    Duara, R
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2000, 8 (01): : 84 - 91
  • [27] Nationwide study of antipsychotic use among community-dwelling persons with Alzheimer's disease in Finland
    Laitinen, Marja-Liisa
    Bell, J. Simon
    Lavikainen, Piia
    Lonnroos, Eija
    Sulkava, Raimo
    Hartikainen, Sirpa
    INTERNATIONAL PSYCHOGERIATRICS, 2011, 23 (10) : 1623 - 1631
  • [28] Efficacy and safety of donepezil over 3 years: an open-label, multicentre study in patients with Alzheimer's disease
    Burns, A.
    Gauthier, S.
    Perdomo, C.
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2007, 22 (08) : 806 - 812
  • [29] Effectiveness and Safety of Donepezil in Hispanic Patients with Alzheimer's Disease: A 12-Week Open-Label Study
    Lopez, Oscar L.
    Mackell, Joan A.
    Sun, Yijun
    Kassalow, Laurent M.
    Xu, Yikang
    McRae, Thomas
    Li, Honglan
    JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2008, 100 (11) : 1350 - 1358
  • [30] A large, community-based, open-label trial of donepezil in the treatment of Alzheimer's disease (AD)
    McRae, T
    Orazem, J
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1999, 47 (09) : S63 - S63
12345